AI perception of Lipid-Lowering Therapies | LucidScope AI Visibility Audit
Key Findings from the LucidScope AI Visibility Analysis The investigational…
How AI Models Are Shaping Perceptions of Cystic Fibrosis Therapies | LucidScope AI Visibility Audit
Key Findings from the LucidScope AI Visibility Analysis of Cystic Fibrosis…
Sickle Cell Gene Therapies Ranked by AI Models | LucidScope AI Visibility Audit
Key Findings from the LucidScope AI Visibility Audit of Casgevy, Lyfgenia,…
AI in Healthcare and Digital Health Today—June 23, 2026
This week’s AI in Healthcare and Digital Health update highlights…
AI in Healthcare and Digital Health Today—June 15, 2026
This week’s AI in Healthcare and Digital Health update highlights…
Lucid Diligence Brief: AlzeCure Pharma Collaboration and Out-Licensing Agreement with Eli Lilly
Lucid Diligence Brief: AlzeCure Pharma Collaboration and Out-Licensing…
AI in Healthcare and Digital Health Today—May 26, 2026
This week’s AI in Healthcare and Digital Health update highlights…
Lucid Diligence Brief: Regeneron collaboration with Parabilis Medicines
Lucid Diligence Brief: Regeneron collaboration with Parabilis Medicines…
AI in Healthcare and Digital Health Today—May 18, 2026
This week’s AI in Healthcare and Digital Health update highlights…
AI in Healthcare and Digital Health Today—May 12, 2026
This week’s AI in Healthcare and Digital Health update highlights…
Lucid Diligence Brief: Basata $21 million Series A
Lucid Diligence Brief: Basata $21 million Series A Professional audiences only.…
Lucid Diligence Brief: Blackstone Life Sciences $250 million investment in Anagram Therapeutics
Lucid Diligence Brief: Blackstone Life Sciences $250 million investment in…